|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||63.57 - 63.99|
|52-week range||58.29 - 66.80|
|PE ratio (TTM)||34.59|
|Earnings date||27 Oct 2017|
|Forward Dividend & Yield||1.88 (2.85%)|
|1y target est||69.95|
Merck & Co. said it is laying off nearly 7% of its U.S. workforce in a reorganization the company says will cut costs and shift focus to products with growth potential.
Drugmaker Merck & Co Inc , moving to a new sales team structure in the United States, plans to cut 1,800 sales positions, while adding 960 jobs to a new chronic care sales force, the company said on Friday. ...
By Deena Beasley (Reuters) - Drugmaker Merck & Co Inc (MRK.N), moving to a new sales team structure in the United States, plans to cut 1,800 sales positions, while adding 960 jobs to a new chronic care ...
Insurers could pay $275 million (209.06 million pounds) to cover the insured portion of drugmaker Merck & Co's loss from a cyber attack in June, according to a forecast by Verisk Analytics Inc's Property Claim Services (PCS) unit. Merck, however, has not disclosed the magnitude of its uninsured losses from the "NotPetya" attack, which disrupted production of some Merck medicines and vaccines. "Merck has not yet fully quantified its losses, much less given any of its insurers an estimate of the total amount of those losses," Merck spokeswoman Claire Gillespie said in a statement.
Insurers could pay $275 million to cover the insured portion of drugmaker Merck & Co's loss from a cyber attack in June, according to a forecast by Verisk Analytics Inc's Property Claim Services unit. ...
AstraZeneca (AZN) said that the FDA has granted priority review to its sNDA for two cancer drugs, Lynparza for an advanced breast cancer indication and Imfinzi for an earlier stage of lung cancer.
The Merck Foundation has launched a five-year initiative: Bridging the Gap: Reducing Disparities in Diabetes Care to help improve diabetes care and health outcomes for vulnerable and underserved populations in the United States.
Large-cap pharmas are expected to report encouraging third-quarter results, following J&J's earnings beat. Five out of the six companies are expected to deliver earnings beat this quarter.
Is Wall Street underestimating Keytruda? Shares of Merck& Co. ( MRK) popped today after Citigroup’s Andrew Baum upgraded the drug maker to Buy from Neutral, and hiked his price target from $65 a share to $72 a share, citing heightened expectations for the blockbuster cancer drug. It’s been a volatile 2017 for Merck.
Keytruda is an immunotherapy drug used in cancer treatments. Citi increased its peak Keytruda sales forecast on the drug to $16 billion from $9 billion.
AstraZeneca and Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted and granted priority review for a supplemental New Drug Application for the use of LYNPARZA® tablets in patients with germline BRCA-mutated , HER2-negative metastatic breast cancer who have been previously treated with chemotherapy either in the neoadjuvant, ...
Merck , known as MSD outside the United States and Canada, today announced the presentation of updated overall survival findings, a secondary endpoint, from the phase 3 KEYNOTE-024 trial evaluating KEYTRUDA® , the company’s anti-PD-1 therapy, as a first-line monotherapy in patients with non-small cell lung cancer whose tumors express high levels of PD-L1 .
"Prescription drug prices are out of control. The drug prices have gone through the roof," Trump says at a Cabinet meeting.
After months of headlines about astronomical drug prices, a funny thing’s happening — drug costs are plummeting.
The pharmaceutical industry puts the cost of bringing a medicine from invention to pharmacy shelves at $2.7 billion. A new paper says it is 'just' $648 million. Unfortunately for pharmaceutical investors and people fighting to control drug prices, alike, the new number doesn’t stand up scrutiny.
To help support innovation in cancer research, Merck , known as MSD outside the United States and Canada, today announced that the company will make a $3 million charitable contribution to Swim Across America.
Merck , known as MSD outside of the United States and Canada, today announced a collaboration with the American Liver Foundation to raise awareness among U.S. veterans about their increased risk for chronic hepatitis C virus infection.
The first placebo-controlled study of two vaccines against the Ebola virus found they both successfully created a powerful antibody response for a year, suggesting they both could be tools to save lives ...
Merck , known as MSD outside the U.S. and Canada, today announced that the company will not submit applications for regulatory approval for anacetrapib, Merck’s investigational cholesteryl ester transfer protein inhibitor.
Merck , known as MSD outside of the United States and Canada, announced results from final analyses of the pivotal Phase III efficacy, immunogenicity, and safety clinical trial for GARDASIL® 9 .
KENILWORTH, N.J.--(BUSINESSWIRE)-- Merck’s 20-year commitment to HPV research highlighted in oral session Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced results from ...